Invitrogen to Present at Pacific Growth Equities Life Sciences Growth Conference

CARLSBAD, Calif.--(BUSINESS WIRE)--June 3, 2005--Invitrogen Corporation (Nasdaq:IVGN) announced today that David F. Hoffmeister, Chief Financial Officer, will present at Pacific Growth Equities Life Sciences Growth Conference in San Francisco on Monday, June 6, at 3:30 p.m. Pacific Time. Mr. Hoffmeister will be commenting on general business matters and will be reaffirming the Company's previously stated guidance.

Mr. Hoffmeister's presentation will be webcast and available for viewing live and after the conference on Invitrogen's website, www.invitrogen.com, in the Investor Relations section of the site.

About Invitrogen Corporation

Invitrogen Corporation (Nasdaq:IVGN) provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bioproduction. Invitrogen's own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery, including functional genomics, proteomics, bioinformatics and cell biology -- placing Invitrogen's products in nearly every major laboratory in the world. Founded in 1987, Invitrogen is headquartered in Carlsbad, and conducts business in more than 70 countries around the world. The company globally employs approximately 4,500 scientists and other professionals and had revenues of more than $1 billion in 2004. For more information about Invitrogen, visit the company's web site at www.invitrogen.com.